rs142889670

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001286445.3(RIPOR2):​c.1613C>T​(p.Ser538Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00102 in 1,613,964 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0038 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00073 ( 3 hom. )

Consequence

RIPOR2
NM_001286445.3 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.39

Publications

9 publications found
Variant links:
Genes affected
RIPOR2 (HGNC:13872): (RHO family interacting cell polarization regulator 2) This gene encodes an atypical inhibitor of the small G protein RhoA. Inhibition of RhoA activity by the encoded protein mediates myoblast fusion and polarization of T cells and neutrophils. The encoded protein is a component of hair cell stereocilia that is essential for hearing. A splice site mutation in this gene results in hearing loss in human patients. [provided by RefSeq, Sep 2016]
RIPOR2 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 104
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal dominant nonsyndromic hearing loss 21
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030991137).
BP6
Variant 6-24843106-G-A is Benign according to our data. Variant chr6-24843106-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445509.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RIPOR2NM_001286445.3 linkc.1613C>T p.Ser538Leu missense_variant Exon 13 of 22 ENST00000643898.2 NP_001273374.1 A0A2R8YEE0B7Z5J9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RIPOR2ENST00000643898.2 linkc.1613C>T p.Ser538Leu missense_variant Exon 13 of 22 NM_001286445.3 ENSP00000494268.2 A0A2R8YEE0

Frequencies

GnomAD3 genomes
AF:
0.00375
AC:
570
AN:
152148
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0122
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00222
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00146
AC:
363
AN:
248878
AF XY:
0.00108
show subpopulations
Gnomad AFR exome
AF:
0.0154
Gnomad AMR exome
AF:
0.00194
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000556
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000435
Gnomad OTH exome
AF:
0.000828
GnomAD4 exome
AF:
0.000728
AC:
1064
AN:
1461698
Hom.:
3
Cov.:
32
AF XY:
0.000673
AC XY:
489
AN XY:
727134
show subpopulations
African (AFR)
AF:
0.0136
AC:
457
AN:
33480
American (AMR)
AF:
0.00174
AC:
78
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.00277
AC:
16
AN:
5768
European-Non Finnish (NFE)
AF:
0.000383
AC:
426
AN:
1111856
Other (OTH)
AF:
0.00123
AC:
74
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
63
125
188
250
313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00378
AC:
575
AN:
152266
Hom.:
2
Cov.:
31
AF XY:
0.00369
AC XY:
275
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0123
AC:
510
AN:
41532
American (AMR)
AF:
0.00222
AC:
34
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000338
AC:
23
AN:
68032
Other (OTH)
AF:
0.00332
AC:
7
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
26
52
77
103
129
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0164
Hom.:
2355
Bravo
AF:
0.00452
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.0137
AC:
55
ESP6500EA
AF:
0.000478
AC:
4
ExAC
AF:
0.00164
AC:
198
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.000600
EpiControl
AF:
0.000474

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 31, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 11, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Aug 23, 2017
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ser559Leu in exon 14 of FAM65B: This variant is not expected to have clinical significance because it has been identified in 1.56% (153/9798) of African chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs142889670). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
7.4
DANN
Benign
0.47
DEOGEN2
Benign
0.0040
T;T;T;.;.;.;T;.;.;.;.;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.027
N
LIST_S2
Benign
0.16
.;T;.;T;T;.;T;T;.;T;T;.;T
MetaRNN
Benign
0.0031
T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.93
T
PhyloP100
1.4
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.66
.;.;N;.;.;N;N;N;.;.;.;.;.
REVEL
Benign
0.049
Sift
Benign
0.65
.;.;T;.;.;T;T;T;.;.;.;.;.
Sift4G
Benign
0.67
.;T;T;.;.;T;T;T;.;.;.;.;.
Polyphen
0.0
B;B;B;.;.;B;B;.;B;B;.;.;.
Vest4
0.047, 0.052, 0.068, 0.073, 0.070
MVP
0.043
MPC
0.27
ClinPred
0.0016
T
GERP RS
4.4
Varity_R
0.025
gMVP
0.14
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142889670; hg19: chr6-24843334; COSMIC: COSV52423869; API